Isoflurane produces antidepressant effects inducing BDNF-TrkB signaling in CUMS mice
The volatile anesthetic isoflurane is suggested to produce a rapid and robust antidepressive effect in preliminary clinical trials. Recently, isoflurane was found to activate the tropomyosin receptor kinase B (TrkB) signaling which is the underlying mechanism of the rapid antidepressant ketamine.
Our study investigated the effect of isoflurane anesthesia on chronic unpredictable mild stressed (CUMS) model in mice and verified the role of brain-derived neurotrophic factor (BDNF)/TrkB/ the mammalian target of rapamycin (mTOR) signaling in the antidepressant effect of isoflurane.
We employed the CUMS model of depression to assess the rapid antidepressant effect of isoflurane by the forced swimming test (FST), the sucrose preference test (SPT), and the novelty suppressed feeding test (NSFT). The protein expression of BDNF and TrkB/protein kinase B (PKB or Akt)/mTOR was determined through Western blot. The dendritic spine density in the hippocampus and medial prefrontal cortex (PFC) was measured by the Golgi staining.
A brief burst-suppressing isoflurane anesthesia rapidly reversed the behavioral deficits caused by CUMS procedure, normalized the expression of BDNF and further activated the TrkB signaling pathway in CUMS-induced stressed mice in both prefrontal cortex (PFC) and hippocampus (HC). All of those behavioral and proteomic effects were blocked by K252a, a selective receptor inhibitor of TrkB. Isoflurane significantly promoted the formation of dendritic spines in both medial prefrontal cortex (mPFC), CA1, CA3, and DG of the hippocampus.
Our study indicates that isoflurane exerts a rapid antidepressant-like effect in CUMS depression animal model, and the activation of BDNF/TrkB signaling pathway plays an indispensable role in the biological and behavioral antidepressant effects of isoflurane. A single exposure to isoflurane could repair synaptic damage caused by chronic stimulation.
KeywordsIsoflurane Rapid antidepressant activity Chronic unpredictable mild stressed Brain-derived neurotrophic factor Tropomyosin receptor kinase B Dendritic spine density
This work was supported by research grants from the National Natural Science Foundation of China (No. 31272397), the Natural Science Foundation of Shandong Province (No. ZR2011CM041), and the Qingdao Postdoctoral Application Research Project (2017).
Compliance with ethical standards
Conflict of interests
The authors declare that they have no conflict of interest.
- Antila H, Ryazantseva M, Popova D, Sipilä P, Guirado R, Kohtala S, Yalcin I, Lindholm J, Vesa L, Sato V, Cordeira J, Autio H, Kislin M, Rios M, Joca S, Casarotto P, Khiroug L, Lauri S, Taira T, Castrén E, Rantamäki T (2017) Isoflurane produces antidepressant effects and induces TrkB signaling in rodents. Sci Rep 7(1):7811CrossRefGoogle Scholar
- Engelhardt W, Carl G, Hartung E (1993) Intra-individual open comparison of burst-suppression-isoflurane-anaesthesia versus electroconvulsive therapy in the treatment of severe depression. Eur J Anaesthesiol 10(2):113–118Google Scholar
- Greenberg LB et al (1987) Isoflurane anesthesia therapy: a replacement for ECT in depressive disorders? Convuls Ther 3(4):269–277Google Scholar
- Heurteaux C, Lucas G, Guy N, el Yacoubi M, Thümmler S, Peng XD, Noble F, Blondeau N, Widmann C, Borsotto M, Gobbi G, Vaugeois JM, Debonnel G, Lazdunski M (2006) Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype. Nat Neurosci 9(9):1134–1141CrossRefGoogle Scholar
- Kato T, et al. (2017) ‘BDNF release and signaling are required for the antidepressant actions of GLYX-13’, Mol PsychiatryGoogle Scholar
- Koinig G, Langer G (1988) Might “isoflurane Narcotherapy” replace ECT? Convuls Ther 4(1):98–99Google Scholar
- Langer G, Karazman R, Neumark J, Saletu B, Schönbeck G, Grünberger J, Dittrich R, Petricek W, Hoffmann P, Linzmayer L, Anderer P, Steinberger K (1995) Isoflurane narcotherapy in depressive patients refractory to conventional antidepressant drug treatment. A double-blind comparison with electroconvulsive treatment. Neuropsychobiology 31(4):182–194CrossRefGoogle Scholar
- Malenka RC, Nestler EJ, Hyman SE (2009) Chapter 8: atypical neurotransmitters. In: Brown RY, Sydor A (eds) Molecular neuropharmacology: a Foundation for clinical neuroscience (2nd ed.). McGraw-Hill Medical, New YorkGoogle Scholar
- Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, Viana MC, Andrade LH, Hu C, Karam EG, Ladea M, Medina-Mora ME, Ono Y, Posada-Villa J, Sagar R, Wells JE, Zarkov Z (2011) Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 68(3):241–251CrossRefGoogle Scholar
- Saarelainen T, Hendolin P, Lucas G, Koponen E, Sairanen M, MacDonald E, Agerman K, Haapasalo A, Nawa H, Aloyz R, Ernfors P, Castrén E (2003) Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurosci 23(1):349–357CrossRefGoogle Scholar
- Si X-M et al. (2018) Low molecular mass chondroitin sulfate suppresses chronic unpredictable mild stress-induced depression-like behavior in mice (68) 361–71Google Scholar
- Tadler S, Light A, Hughen R (2009) Isoflurane demonstrates antidepressant-like activity in a mouse model of depression (Abstract). Anesth Analg 108:212Google Scholar
- WHO ‘Depression Fact Sheet’, [Internet], (updated 22 March 2018a) <http://www.who.int/news-room/fact-sheets/detail/depression>, Accessed 22 MarchGoogle Scholar
- WHO ‘Suicide Fact Sheet’ [Internet]. <http://www.who.int/news-room/fact-sheets/detail/depression>, Accessed 24 Aug 2018bGoogle Scholar
- Willner P (2017) The chronic mild stress (CMS) model of depression: history, evaluation and usage. Neurobiol Stress 6:78–93Google Scholar
- Xu A, Cui S, Wang J-H (2015) Incoordination among Subcellular Compartments Is Associated with Depression-Like Behavior Induced by Chronic Mild Stress (19) pyv122Google Scholar
- Zanos P, Moaddel R, Morris PJ, Georgiou P, Fischell J, Elmer GI, Alkondon M, Yuan P, Pribut HJ, Singh NS, Dossou KSS, Fang Y, Huang XP, Mayo CL, Wainer IW, Albuquerque EX, Thompson SM, Thomas CJ, Zarate Jr CA, Gould TD (2016) NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 533(7604):481–486CrossRefGoogle Scholar